Diversified Trust CO Vertex Pharmaceuticals Inc Transaction History

Diversified Trust CO

$2.93 Billion
Q2 2024

A detailed history of Diversified Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Diversified Trust CO holds 1,550 shares of VRTX stock, worth $745,953. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,550

Previous 1,455 6.53%

Holding current value

$745,953

Previous $608,000 19.41%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$392.81 - $485.53 $37,316 - $46,125	95 Added 6.53%	1,550 $726,000
Q1 2024 Apr 18, 2024	SELL	$407.69 - $446.08 $200,991 - $219,917	-493 Reduced 25.31%	1,455 $608,000
Q4 2023 Jan 08, 2024	BUY	$343.0 - $410.68 $5,831 - $6,981	17 Added 0.88%	1,948 $792,000
Q3 2023 Nov 17, 2023	SELL	$338.18 - $362.46 $153,533 - $164,556	-454 Reduced 19.04%	1,931 $671,000
Q2 2023 Jul 18, 2023	BUY	$314.42 - $351.91 $247,134 - $276,601	786 Added 49.16%	2,385 $839,000
Q1 2023 Apr 07, 2023	SELL	$283.23 - $323.1 $204,208 - $232,955	-721 Reduced 31.08%	1,599 $503,000
Q4 2022 Jan 17, 2023	BUY	$285.76 - $321.48 $158,025 - $177,778	553 Added 31.3%	2,320 $670,000
Q3 2022 Oct 14, 2022	BUY	$273.83 - $305.53 $136,093 - $151,848	497 Added 39.13%	1,767 $512,000
Q2 2022 Jul 12, 2022	SELL	$234.96 - $292.55 $327,769 - $408,107	-1,395 Reduced 52.35%	1,270 $358,000
Q1 2022 Apr 07, 2022	BUY	$221.42 - $260.97 $10,185 - $12,004	46 Added 1.76%	2,665 $695,000
Q4 2021 Jan 13, 2022	SELL	$177.01 - $223.45 $94,700 - $119,545	-535 Reduced 16.96%	2,619 $575,000
Q3 2021 Jan 13, 2022	SELL	$181.39 - $202.99 $88,699 - $99,262	-489 Reduced 13.42%	3,154 $572,000
Q2 2021 Jul 20, 2021	BUY	$187.49 - $221.1 $63,184 - $74,510	337 Added 10.19%	3,643 $735,000
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $22,151 - $25,820	107 Added 3.34%	3,306 $710,000
Q3 2020 Oct 15, 2020	BUY	$255.65 - $303.1 $314,960 - $373,419	1,232 Added 62.63%	3,199 $871,000
Q2 2020 Jul 07, 2020	BUY	$225.48 - $295.8 $74,408 - $97,614	330 Added 20.16%	1,967 $571,000
Q1 2020 Apr 10, 2020	BUY	$199.77 - $247.81 $2,197 - $2,725	11 Added 0.68%	1,637 $390,000
Q4 2019 Jan 09, 2020	BUY	$166.71 - $223.91 $271,070 - $364,077	1,626 New	1,626 $356,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.

Account

Diversified Trust CO Vertex Pharmaceuticals Inc Transaction History